Bionano Genomics, Inc. (BNGO) vs Vyome Holdings, Inc. (HIND)
A side-by-side comparison of Bionano Genomics, Inc. and Vyome Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BNGO
Bionano Genomics, Inc.
$1.46HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
HIND
Vyome Holdings, Inc.
$1.99HealthcareDelayed quote: Oct 6, 2026, 11:32 AM EDT
Total return — BNGO vs HIND
growth of $100 · dividends reinvested · last 8yBNGO -100.0% (-62.5%/yr)HIND -100.0% (-87.0%/yr)BNGO compounded faster over this window
Log scale — wide-divergence pair
BNGO HIND
BNGO vs HIND: by the numbers
- •BNGO is the larger company ($17M vs $14M market cap).
- •Both run net losses; BNGO's is the smaller (-106.58% vs -8716.77% net margin).
- •BNGO grew revenue faster over the past five years (17.97% vs -60.54% CAGR).
Metrics side by side
Valuation
| Metric | BNGO | HIND |
|---|---|---|
| P/S ratio | 0.55 | 107.67 |
| P/B ratio | 0.53 | 2.31 |
| FCF yield | N/A | 3.76% |
Profitability
| Metric | BNGO | HIND |
|---|---|---|
| Gross margin | 21.95% | 64.68% |
| Operating margin | -116.95% | -859.22% |
| Net margin | -106.58% | -8716.77% |
| ROE | -101.76% | -186.95% |
| ROIC | -85.72% | -57.53% |
Growth (annualized)
| Metric | BNGO | HIND |
|---|---|---|
| Revenue CAGR (5Y) | 17.97% | -60.54% |
| Total return CAGR (5Y) | -78.37% | -92.93% |
Frequently asked
- Which has grown faster, BNGO or HIND?
- Over the past five years, BNGO grew revenue faster — BNGO at a 17.97% CAGR versus HIND at -60.54%.
- How have BNGO and HIND total returns compared?
- Over the past 5 years, BNGO delivered -78.37% and HIND delivered -92.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bionano Genomics ROEVyome ROEBionano Genomics operating marginVyome operating marginBionano Genomics revenue growthVyome revenue growthBionano Genomics free cash flowVyome free cash flow
Bionano Genomics & Vyome appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.